### Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI
[Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI](https://www.certara.com/blog/cant-chatgpt-do-that-practical-applications-for-ai-in-drug-discovery-development/)

### Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design
[Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design](https://www.certara.com/blog/mathematical-modeling-and-the-monkey-king-use-of-modeling-for-more-efficient-nhp-study-design/)

### 4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development
[4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development](https://www.certara.com/blog/4-ways-that-mechanistic-modeling-accelerates-bispecific-and-multispecific-antibody-drug-development/)

### Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
[Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome](https://www.certara.com/blog/modeling-immunotherapy-induced-cytokine-release-syndrome/)

### Drug Discovery Platform Unlocks Scientific Data Access
[Drug Discovery Platform Unlocks Scientific Data Access](https://www.certara.com/blog/drug-discovery-platform-unlocks-scientific-data-access/)

### How Drug Discovery Tools Aid Pharma Decision-Making
[How Drug Discovery Tools Aid Pharma Decision-Making](https://www.certara.com/blog/how-drug-discovery-tools-aid-pharma-decision-making/)